AH Bio Fund III, L.P.
- SEC CIK
- 0001799477
In the past year, 1 open-market purchase filing worth $5.00M and no sales.
Current role at each company
- SCTX Scribe Therapeutics, Inc.10% Owneras of Jul 29, 2026
- EQRX EQRx, Inc.10% Owneras of Nov 9, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $5.00M
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$5.00M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists AH Bio Fund III, L.P. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
SCTX Scribe Therapeutics, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 29, 2026 (view filing)7:09 PM ET | Jul 27 | 2 days | Andreessen Marc L and 5 others10% Owner | PPurchase | +333.3K | $15.00 | +$5.00M | +16.2%2.39M after |